paxilline and cx 4945
paxilline has been researched along with cx 4945 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hwan Kim, S; Kim, J | 1 |
| Choi, WJ; Jung, J; Kim, J; Kim, SH; Lee, JO; Moon, SH; Park, JK | 1 |
Other Studies
2 other study(ies) available for paxilline and cx 4945
| Article | Year |
|---|---|
CK2 inhibitor CX-4945 blocks TGF-β1-induced epithelial-to-mesenchymal transition in A549 human lung adenocarcinoma cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Cadherins; Casein Kinase II; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Focal Adhesion Kinase 1; Humans; Lung Neoplasms; Naphthyridines; Neoplasm Invasiveness; Paxillin; Phenazines; Protein Kinase Inhibitors; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1; Wnt Proteins | 2013 |
Micropillar arrays as potential drug screens: Inhibition of micropillar-mediated activation of the FAK-Src-paxillin signaling pathway by the CK2 inhibitor CX-4945.
Topics: Apoptosis; Biological Assay; Casein Kinase II; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Activation; Equipment Design; Equipment Failure Analysis; Focal Adhesion Kinase 1; Humans; Lung Neoplasms; Mechanotransduction, Cellular; Naphthyridines; Paxillin; Phenazines; src-Family Kinases; Tissue Array Analysis; Treatment Outcome | 2015 |